Crossmark

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.222

Published Online: 2016-01-20

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Di Maio, Massimo

Basch, Ethan

Bryce, Jane

Perrone, Francesco
License Information

Text and Data Mining valid from 2016-01-20
More Information

Article History

First Online: 20 January 2016

Change Date: 27 January 2016

Change Type: Correction

Change Details: In the original version of this article published online, the title and doi of reference 43 was incorrect. These errors have been corrected in the online and print versions of the article.

Competing interests

: E.B. has received research funding from the US National Cancer Institute for developing the PRO–CTCAE. The other authors declare no competing interests.